Medicine and Health
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
Y. Higuchi, T. Suzuki, et al.
This groundbreaking research, conducted by Yusuke Higuchi and colleagues, presents an engineered high-affinity human ACE2 receptor that neutralizes SARS-CoV-2 effectively, showcasing its potential to combat the virus and prevent escape mutants. The study demonstrates significant protection against the virus in hamsters, suggesting a promising therapeutic approach.
Related Publications
Explore these studies to deepen your understanding of the subject.

